Refractive error is the most common eye disorder worldwide and is a prominent cause of blindness. Myopia affects over 30% of Western populations and up to 80% of Asians. The CREAM consortium conducted genome-wide meta-analyses, including 37,382 individuals from 27 studies of European ancestry and 8,376 from 5 Asian cohorts. We identified 16 new loci for refractive error in individuals of European ancestry, of which 8 were shared with Asians. Combined analysis identified 8 additional associated loci. The new loci include candidate genes with functions in neurotransmission (GRIA4), ion transport (KCNQ5), retinoic acid metabolism (RDH5), extracellular matrix remodeling (LAMA2 and BMP2) and eye development (SIX6 and PRSS56). We also confirmed previously reported associations with GJD2 and RASGRF1. Risk score analysis using associated SNPs showed a tenfold increased risk of myopia for individuals carrying the highest genetic load. Our results, based on a large meta-analysis across independent multiancestry studies, considerably advance understanding of the mechanisms involved in refractive error and myopia.
from 27 populations of European ancestry (Supplementary
and Supplementary Note) using spherical equivalent as a continuous outcome. In the second stage, we aimed to test the cross-ancestry transferability of the statistically significant associations from the first stage in 8,376 individuals from 5 Asian cohorts (Supplementary Table 1 and Supplementary Note). In the third stage, we performed a GWAS metaanalysis on the combined populations (total n = 45,758). Subsequently, we examined the influence of associated alleles on the risk of myopia in a genetic risk score analysis, and, lastly, we evaluated gene expression in ocular tissues and explored potential mechanisms by which newly found loci might exert their effects on refractive development.
In stage 1, we analyzed ~2.5 million autosomal SNPs for which data were obtained through whole-genome imputation of genotypes to HapMap 2. The inflation factors (λ GC ) of the test statistics in individual studies contributing to the meta-analysis ranged between 0.992 and 1.050, indicating excellent within-study control of population substructure (Supplementary Table 2 ). Overall λ was 1.09, consistent with a polygenic inheritance model for refractive error (quantilequantile plot; Supplementary Fig. 1 ). We did not perform a correction for λ, as it has been shown that, under polygenic inheritance, substantial genomic inflation can be expected, even in the absence of population structure and technical artifacts 11 . We identified 309 SNPs that exceeded the conventional genome-wide significance threshold of P = 5.0 × 10 −8 in the European ancestry sample. These SNPs were Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia A full list of authors and affiliations appears at the end of the paper. Figure 1 Manhattan plot of the GWAS meta-analysis for refractive error in the combined analysis (n = 45,758). The plot shows −log 10 -transformed P values for all SNPs. The upper horizontal line represents the genome-wide significance threshold of P < 5.0 × 10 −8 ; the lower line indicates P value of 1 × 10 −5 . Previously reported genes are shown in gray. The RBFOX1 gene is also known as A2BP1. l e t t e r s clustered in 18 distinct genomic regions across 14 chromosomes ( Fig. 1 and Table 1) . In stage 2, we investigated the 18 best-associated SNPs in the Asian population: 10 showed evidence of association ( Table 1) . The most significant association in both ancestry groups was at a previously identified locus on chromosome 15q14 in the proximity of the GJD2 gene (encoding the connexin 36 gap-junction protein; rs524952; P combined = 1.44 × 10 −15 ) 4, 12 . The locus near the RASGRF1 gene (encoding Ras protein-specific guanine nucleotidereleasing factor 1) was also replicated in the meta-analysis (rs4778879; P combined = 4.25 × 10 −11 ) 9 . The remaining 16 loci associated at genomewide significance had not previously been reported in association with refractive error. Those loci that did not show significant association in the smaller sized Asian population mostly had a similar effect size and direction of effect as in the European ancestry sample. In stage 3, we identified eight additional loci with associations that exceeded genome-wide significance in the combined analysis ( Table 2) . Regional and forest plots of the associated loci are provided in Supplementary Figures 2 and 3 , respectively.
Genotype distributions of the risk alleles were evaluated in Rotterdam Studies 1-3 (n = 9,307). The clinical usefulness for the prediction of risk of myopia was evaluated by a weighted genetic risk score analysis based on the aggregate of effects (β regression coefficients) of individual SNPs derived from the meta-analysis, using the middle risk category as a reference. Risk scores ranged from a mean risk score of 1.88 (95% confidence interval (CI) = 1.86-1.89) in the lowest risk score category to 3.63 (95% CI = 3.61-3.65) in the highest risk score category. Having the lowest or the highest genetic risk score was associated with an odds ratio (OR) of 0.38 (95% CI = 0.18-0.77) and an OR of 10.97 (95% CI = 3.73-31.25) of myopia, respectively (Fig. 2) . The predictive value (area under the receiver operating characteristic curve, AUC) of myopia versus hyperopia was 0.67 (95% CI = 0.65-0.69), a relatively high value for genetic factors in a complex trait 13, 14 . The genetic variants explained 3.4% of the phenotypic variation in refractive error in the Rotterdam Study.
We examined the expression of genes harboring a genetic association signal by measuring the levels of RNA in various eye tissues and found most of these genes expressed in the eye (Supplementary Table 3 ). Expression data for the PRSS56, LOC100506035 and SHISA6 genes were not available; all other genes were expressed in the retina. Subsequently, we assessed the areas with associated SNPs for acetylation at histone H3 lysine 27 (H3K27ac) modifications 15 and HaploReg 16 annotations for marks of active regulatory elements ( Supplementary Fig. 4 and Supplementary Table 4). We found that many associated loci contained these elements, and alteration of regulatory function is therefore a potential mechanism.
The widely accepted model for myopia development is that eye growth is triggered by a visually evoked signaling cascade, which originates from the sensory retina, traverses the retinal pigment epithelium (RPE) and choroid and terminates in the sclera, where active extracellular matrix (ECM) remodeling results in a relative elongation of the eye 17 . Many of the genes in or near the identified loci can be linked to biological processes that drive this cascade. Neurotransmission in the retina is a necessary mechanism for eye growth regulation; the most significantly associated gene GJD2 has a role in this process. This gene forms a gap junction between neuronal cells in the retina, enabling the intercellular exchange of small molecules and ions. The other previously reported gene RASGRF1 is a nuclear exchange factor that promotes the exchange of GTP for GDP on Ras family GTPases and is involved in the synaptic transmission of photoreceptor responses 18, 19 . Both GJD2 and RASGRF1 knockout mice show retinal photoreception defects 18, 20 . One of the newly 3 1 6 VOLUME 45 | NUMBER 3 | MARCH 2013 Nature GeNetics l e t t e r s identified genes, GRIA4 (encoding glutamate receptor, ionotropic, AMPA 4; rs11601239; P combined = 5.92 × 10 −9 ), also has a potential function in this pathway. This gene encodes a glutamate-gated ion channel that mediates fast synaptic excitatory neurotransmission 21 , is present in various retinal cells 22 and has been shown to be critical for light signaling in the retina 23 and emmetropization 24 . Another gene involved in synaptic transmission is RBFOX1 (encoding RNA-binding protein, fox-1 homolog; also known as A2BP1; rs17648524; P combined = 5.64 × 10 −10 ), encoding an RNA-binding splicing regulator that modulates membrane excitability 25 .
We identified for the first time a number of candidate genes involved in ion transport, channel activity and the maintenance of membrane potential. KCNQ5 (encoding a member of the potassium voltage-gated channel KQT-like subfamily; rs7744813; P combined = 4.18 × 10 −9 ), participates in the transport of potassium ions from the retina to the choroid and may contribute to voltage-gated potassium ion channels in the photoreceptors and retinal neurons associated with myopia 26, 27 . CD55 (encoding a decay-accelerating factor for complement; rs1652333; P combined = 3.05 × 10 −12 ) is known to elevate cytosolic calcium ion concentration. Other ion channel genes that were associated include CACNA1D (encoding a voltage-sensitive calcium channel regulator; rs14165; P combined = 2.14 × 10 -8 ), KCNJ2 (encoding a regulator of potassium ion transport; rs4793501; P combined = 2.79 × 10 -8 ), CHRNG (encoding a nicotinic cholinergic receptor; rs1881492; P combined = 2.15 × 10 -11 ) and MYO1D (encoding a putative binder of calmodulin; rs17183295; P combined = 9.66 × 10 -11 ), which mediates calcium ion sensitivity to KCNQ5 ion channels.
Retinoic acid is synthesized in the retina, is highly expressed in the choroid and has been implicated in eye growth in experimental myopia models [28] [29] [30] . RDH5 (encoding retinol dehydrogenase 5; rs3138144; P combined = 4.44 × 10 -12 ), a new refractive error susceptibility gene is involved in the recycling of 11-cis-retinal in the visual cycle 31 . Mutations in RDH5 cause congenital stationary night blindness (MIM 136880), a disease associated with myopia.
Other genes involved in retinoic acid metabolism are RORB (encoding RAR-related orphan receptor; rs7042950; P combined = 4.15 × 10 -8 ) and CYP26A1 (encoding a member of the cytochrome P450 superfamily; rs10882165; P combined = 1.03 × 10 -11 ), genes that showed significant associations in the European ancestry studies. Notably, retinoic acid contributes to ECM remodeling by regulating cell differentiation.
ECM remodeling of the sclera is the pathological hallmark of myopia development. LAMA2 (encoding laminin α2; rs12205363; P combined = 1.79 × 10 −12 ) is the most prominent gene in this respect. The LAMA2 protein forms a subunit of the heterotrimer laminins, which are essential components of basement membranes, stabilizing cellular structures and facilitating cell migration 32 . Two genes encoding bone morphogenetic proteins (BMP2: rs235770; P combined = 1.57 × 10 −8 and BMP3: rs1960445; P stage 1 = 1.19 × 10 -8 ; P combined = 1.25 × 10 -6 ) also have a role in the ECM architecture. They are members of the transforming growth factor (TGF)-β superfamily, regulate the growth and differentiation of mesenchymal cells and may orchestrate the organization of other connective tissues than bone, such as sclera. Notably, BMP2 shows expression in RPE in animal models of myopia 33 .
Genes involved in eye development appeared as a separate entity among the gene functions. SIX6 (encoding SIX homeobox 6; rs1254319; P combined = 1.00 × 10 −8 ) has been linked to anophthalmia and glaucoma 34, 35 , PRSS56 (encoding protease serine 56, rs1656404; P combined = 7.86 × 10 −11 ) has been linked to microphthalmia [36] [37] [38] , CHD7 (encoding chromodomain helicase DNA-binding protein 7; rs4237036; P combined = 1.82 × 10 -8 ) has been linked to CHARGE syndrome, a congenital condition with severe eye structural defects, and ZIC2 (encoding a member of the ZIC family of C2H2-type zincfinger proteins; rs8000973; P combined = 5.10 × 10 -8 ) has been linked to brain development, including visual perception. For the remaining new associated loci, a mechanism in the pathogenesis of myopia is not immediately clear. Results from Ingenuity and the Protein Link Evaluator 39 (Supplementary Fig. 5 ) map the subcellular location of all associated gene products and show their inter-relationships. Direct connections between genes were infrequent, suggesting molecular l e t t e r s disease heterogeneity or functional redundancy in the pathobiological events involved in the development of refractive error and myopia. In summary, we identified 24 new loci associated with refractive error through a large-scale meta-analysis of GWAS from international multiancestry studies. The substantial overlap in genetic loci for refractive error between individuals of European ancestry and Asians provides evidence for shared genetic risk factors between the populations. The tenfold increased risk of myopia for those carrying the highest number of risk alleles shows the clinical significance of our findings. Further elucidation of the mechanisms by which these loci affect eye growth carries the potential to improve the visual outcome of this common trait.
URLs. R, http://www.r-project.org/; LocusZoom, http://csg.sph. umich.edu/locuszoom/; Ingenuity, http://www.ingenuity.com/.
METhOdS
Methods and any associated references are available in the online version of the paper.
Accession codes. Data on RPE gene expression have been deposited at the Gene Expression Omnibus (GEO) under accession GSE20191.
ONLINE METhOdS
Study design. We performed a meta-analysis on directly genotyped and imputed SNPs from individuals of European ancestry in 27 studies, with a total of 37,382 individuals. Subsequently, we evaluated significantly associated SNPs in 8,376 subjects of Asian origin from 5 different studies and performed a meta-analysis on all studies combined.
Subjects and phenotyping.
All studies participating in this meta-analysis are part of CREAM. All studies had a population-based design and had a similar protocol for phenotyping (Supplementary Table 1) . Eligible participants underwent a complete ophthalmological examination, including a non-dilated measurement of refractive error for both eyes. Exclusion criteria were all conditions that could alter refraction, such as cataract surgery, laser refractive procedures, retinal detachment surgery, keratoconus or ocular or systemic syndromes. Inclusion criteria included age of 25 years and over and data on refractive error and genotype.
The meta-analysis of stage 1 was based on 27 studies of European ancestry: 1958 British Birth Cohort, ALSPAC, ANZRAG, AREDS1a1b, AREDS1c, CROATIA-Korcula, CROATIA-Split, CROATIA-Vis, EGCUT, FECD, TEST/ BATS, FITSA, Framingham, GHS 1, GHS 2, KORA, ORCADES, TwinsUK, WESDR, YFS, ERF, DCCT, BMES, RS1, RS2, RS3 and OGP Talana. Stage 2 comprised 5 Asian studies: Beijing Eye Study, SCES, SIMES, SINDI and SP2.
Information on general methods, demographics and phenotyping and genotyping methods of the study cohorts can be found in Supplementary Table 1 and the Supplementary Note. All studies were performed with the approval of their local medical ethics committee, and written informed consent was obtained from all participants in accordance with the Declaration of Helsinki.
Genotyping and imputation. Information on genotyping in each cohort, the particular platforms used to perform genotyping and the methods of imputation can be found in more detail in Supplementary Table 5 . To produce consistent data sets and enable meta-analysis of studies across different genotyping platforms, the studies performed genomic imputation on available HapMap Phase 2 genotypes with MACH 40 or IMPUTE 41 , using the appropriate ancestry groups as templates.
Each study applied stringent quality control procedures before imputation, including MAF cutoffs, Hardy-Weinberg equilibrium (P > 1 × 10 −7 ), genotypic success rate (>95%), mendelian inconsistencies, exclusion of individuals with more than 5% shared ancestry (exception made for family-based cohorts in which due adjustment for family relationship was made) and removal of all individuals whose ancestry as determined through genetic analysis did not match the prevailing ancestry group of the corresponding cohort. SNPs with low imputation quality were filtered using metrics specific to the imputation method and thresholds used in previous GWAS analyses. Hence, imputation quality criteria varied slightly between studies, and low-confidence imputed SNPs were omitted in the meta-analysis for individual studies.
Statistical analysis. Spherical equivalent was calculated according to the standard formula (SE = sphere + 1/2 cylinder), and the mean value from two eyes was used for analysis. When data from only one eye was available, the spherical equivalent of this eye was used.
Each cohort performed association analyses in which the spherical equivalent was the dependent variable and genotypes (number of alleles in each of the HapMap 2 loci) were the independent variables. Analyses in all cases also adjusted for sex and age at the time of phenotype measurement. In familybased cohorts, a score test-based association test was used to adjust for withinfamily relatedness (Supplementary Note) 42, 43 . Study-specific λ estimates are shown in Supplementary Table 2 .
All study effect estimates were corrected using genomic control and were oriented to the positive strand of the NCBI Build 36 reference sequence of the human genome, which was the genomic build on which most available genotyping platforms were based. Coordinates and further annotations for the SNPs were converted into Build 37, the most recent version of the available builds at the time of writing.
Meta-analyses used effect size estimations (β regression coefficients) and standard errors from individual cohorts' summary statistics. Random effects were assumed for all the meta-analyses that were performed using GWAMA 44 .
We tested for heterogeneous effects between the two ancestry groups using METAL 45 for Linux. For the purpose of these analyses, we defined significance as equal to or better than the conventional multiple-testing genome-wide thresholds of association (P < 5.0 × 10 −8 ) for stage 1 and nominally significant probabilities (P < 0.05) for stage 2. Manhattan, regional and forest plots were made using R (see URLs) and LocusZoom (see URLs) 46 .
For the Rotterdam Study 1-3, a weighted genetic risk score per individual was calculated using the regression coefficients from the GWAS meta-analysis model for the association of SNPs within the associated 26 loci (Tables 1 and 2 ; for each locus, only one SNP was included in the analysis) and the individual allele dosages per genotype to evaluate the relationships between myopia (SE ≤ −3 D), emmetropia (-1.5 D ≤ SE ≤ 1.5 D) and hyperopia (SE ≥ 3 D). The weighted risk scores were categorized, and mean ORs per risk score category were calculated for subjects with myopia versus hyperopia, using the middle risk score category as a reference. Subsequently, AUCs were calculated for myopia versus emmetropia and myopia versus hyperopia. Lastly, the proportion of variance of spherical equivalent explained by the identified SNPs was calculated. For these analyses, we used SPSS version 20.0.0.
Gene expression data in human eye tissue. Independently designed, collected and reported human ocular tissue array data from two different sources, as well as literature reviews, were used to verify evidence of expression of the candidate genes.
RPE, photoreceptors and choroid. Human gene expression data for RPE, photoreceptors and choroid were obtained essentially as described 47 , and the data set has been deposited in NCBI's Gene Expression Omnibus 48 (accession GSE20191). In short, postmortem eye bulbs (RPE was obtained from six donor eyes, choroid was obtained from three donor eyes and photoreceptors were obtained from three donor eyes), provided by the Corneabank Amsterdam, were rapidly frozen using liquid nitrogen. Donors were between 63 and 78 years old and had no known history of eye pathology. Cryosections were cut from the macula, and histology was used to confirm a normal histological appearance. RPE, photoreceptor and choroidal cells were isolated from macular sections using the Laser Microdissection System (PALM). Total RNA was isolated, and the mRNA component was amplified, labeled and hybridized to a 44K microarray (Agilent Technologies) 49 . At least three to six microarrays were performed per tissue. Sample isolation, procedures and expression microarray analysis were carried out according to MIAMI guidelines. To bring order in the level of expression, we sorted all the genes represented on the 44K microarray by increasing expression, and we calculated the corresponding percentiles (Supplementary Table 3a) .
Sclera, cornea and optic nerve. We assessed expression of the associated genes in sclera, cornea and optic nerve tissue in an additional data set (data not shown). Adult eyes were obtained from the North Carolina Eye Bank (Winston-Salem, North Carolina). All whole globes were immersed in RNALater (Qiagen) within 6.5 h of collection, shipped overnight on ice and dissected on the day of arrival. The retina, choroid and sclera tissues were isolated at the posterior pole using a circular, double-embedded technique using round 7-mm and 5-mm biopsy punches. To reduce contamination of the retina to the other ocular tissue samples, the second biopsy punch of 5 mm was used in the center of the 7-mm punch after retinal removal. RNA samples (with quality control of RNA concentration and 260/280 nm ratios performed using Nanodrop; Invitrogen) were hybridized to whole-genome microaray Illumina HumanHT-12 v4 Expression BeadChips (with over 25,000 genes and 48,000 probes) in 2 batches. The first batch was hybridized to adult RPE, choroid and sclera RNA samples (n = 6). The second batch of newer chips with additional probes was hybridized to adult optic nerve and cornea samples (n = 6). The data were exported from Illumina GenomeStudio and were log 2 transformed. Sample outliers were determined by principal-component analyses using the Hoteling's T2 test 50 (at 95% confidence interval) and removed from further analyses. Data intensity was normalized by quantile normalization followed by multichip averaging 51 to reduce chip effects. For each tissue type, the probes with signal intensities below background levels and those with the lowest (5%) signal intensities (detection P < 0.10) were excluded. Evidence of expression for the remaining probes was defined by detection P < 0.05. Probes with detection P < 0.10 or > 0.05 required additional tissue expression support from EyeSAGE or literature reports (Supplementary Table 3b) .
